{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:02:10Z","timestamp":1789563730058,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2023\/51\/B\/NZ4\/01016"],"award-info":[{"award-number":["2023\/51\/B\/NZ4\/01016"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Melanoma is an aggressive cancer characterized by metabolic reprogramming that supports invasion and metastasis. Receptor-interacting protein kinase 4 (RIPK4) has been linked to tumor progression, but its role in melanoma metabolism remains unclear. This study examined whether RIPK4 is associated with melanoma aggressiveness through modulation of cellular bioenergetics. Previously generated RIPK4-knockout A375 and WM266.4 melanoma cell lines (CRISPR\/Cas9) were used, and RIPK4 expression was restored by plasmid transfection. Cellular metabolism was assessed using the Seahorse XF Mito Stress Test in 2D monolayer cultures. In 3D spheroid models, ATP assays, qRT-PCR, and Western blotting were performed, together with functional analyses using 3D matrix invasion and CCID assays. In vivo relevance was evaluated by immunohistochemical analysis of RIPK4 and GLUT1 in lung metastases from NOD\/SCID mouse xenografts. RIPK4 knockout induced a metabolically compromised state, characterized by reduced mitochondrial respiration and glycolysis, decreased HK2 and GLUT1 expression, and increased SDHB levels also impaired 3D invasive behavior, including reduced formation of invasive protrusions and decreased intravascular invasion. GLUT1 expression was detected in lung metastases but was reduced in RIPK4-deficient tumors. RIPK4 re-expression restored AKT phosphorylation and partially rescued HK2 and GLUT1 levels; however, metabolic flux (OCR\/ECAR) was not recovered. These findings suggest that RIPK4 is associated with melanoma metabolic regulation and invasion, potentially involving AKT-linked signaling, but also indicate that additional mechanisms beyond AKT\u2013GLUT1 contribute to the observed metabolic phenotype.<\/jats:p>","DOI":"10.1038\/s41598-026-59563-y","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:24:14Z","timestamp":1782231854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RIPK4 is associated with altered bioenergetics and invasive in melanoma three-dimensional models"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1084-175X","authenticated-orcid":false,"given":"Norbert","family":"Wronski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6776-5643","authenticated-orcid":false,"given":"Jan","family":"Wolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-1050","authenticated-orcid":false,"given":"Wac\u0142aw","family":"Tworzyd\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-1297","authenticated-orcid":false,"given":"Aleksandra","family":"Bienia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-1009","authenticated-orcid":false,"given":"Justyna","family":"Gogola-Mruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3195-9965","authenticated-orcid":false,"given":"Anna A.","family":"Bro\u017cyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-1918","authenticated-orcid":false,"given":"Anna","family":"Ptak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-6349","authenticated-orcid":false,"given":"Agnieszka","family":"Wolnicka-Glubisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"59563_CR1","unstructured":"Sundararajan, S., Thida, A. M., Yadlapati, S., Mukkamalla, S. K. R. & Koya, S. Metastatic Melanoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 29262232. (2024)."},{"key":"59563_CR2","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3389\/fonc.2020.01562","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu, J., Wei, Q. & He, Z. Insight Into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis. Front. Oncol. 10, 1562 (2020).","journal-title":"Front. Oncol."},{"key":"59563_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/onc.2013.551","volume":"34","author":"D Heim","year":"2015","unstructured":"Heim, D. et al. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis. Oncogene 34, 364\u2013372 (2015).","journal-title":"Oncogene"},{"key":"59563_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/cdd.2017.81","volume":"24","author":"J Kopparam","year":"2017","unstructured":"Kopparam, J. et al. RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation. Cell. Death Differ. 24, 1761\u20131771 (2017).","journal-title":"Cell. Death Differ."},{"key":"59563_CR5","doi-asserted-by":"crossref","unstructured":"Liao, C., Zhao, Y., Han, W. & Lai, N. RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer. J. Immunol. Res. 1\u201321 (2022). (2022).","DOI":"10.1155\/2022\/7599098"},{"key":"59563_CR6","doi-asserted-by":"crossref","unstructured":"Qi, Z. H. et al. RIPK4\/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1\/MEK\/ERK signaling. Int. J. Oncol. 52, 1105\u20131116 Erratum in: Int J Oncol. 68, 9 (2026). (2018).","DOI":"10.3892\/ijo.2018.4269"},{"key":"59563_CR7","doi-asserted-by":"publisher","first-page":"110938","DOI":"10.1016\/j.cellsig.2023.110938","volume":"113","author":"N Wronski","year":"2024","unstructured":"Wronski, N., Madej, E., Grabacka, M., Bro\u017cyna, A. A. & Wolnicka-Glubisz, A. RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt\/\u03b2-catenin signaling in melanoma cells and tumor growth in vivo. Cell. Signal. 113, 110938 (2024).","journal-title":"Cell. Signal."},{"key":"59563_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/1878-0261.70220","volume":"20","author":"N Wronski","year":"2026","unstructured":"Wronski, N. et al. RIPK4 function interferes with melanoma cell adhesion and metastasis. Mol. Oncol. 20, 1115\u20131139 (2026).","journal-title":"Mol. Oncol."},{"key":"59563_CR9","doi-asserted-by":"publisher","first-page":"11504","DOI":"10.3390\/ijms222111504","volume":"22","author":"E Madej","year":"2021","unstructured":"Madej, E. et al. Deciphering the Functional Role of RIPK4 in Melanoma. Int. J. Mol. Sci. 22, 11504 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"59563_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/cancers15030918","volume":"15","author":"E Madej","year":"2023","unstructured":"Madej, E. et al. Vemurafenib and Dabrafenib Downregulates RIPK4 Level. Cancers (Basel). 15, 918 (2023).","journal-title":"Cancers (Basel)"},{"key":"59563_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00432-024-05732-3","volume":"150","author":"E Madej","year":"2024","unstructured":"Madej, E. et al. The involvement of RIPK4 in TNF-\u03b1-stimulated IL-6 and IL-8 production by melanoma cells. J. Cancer Res. Clin. Oncol. 150, 209 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"59563_CR12","doi-asserted-by":"crossref","unstructured":"Yi, Z. et al. Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt\/\u03b2-catenin signaling pathway in osteosarcoma. Mol. Med. Rep. 21, 1154\u20131162 Erratum in: Mol Med Rep. 25, 69 (2022). (2020).","DOI":"10.3892\/mmr.2022.12585"},{"key":"59563_CR13","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","volume":"186","author":"LWS Finley","year":"2023","unstructured":"Finley, L. W. S. What is cancer metabolism? Cell 186, 1670\u20131688 (2023).","journal-title":"Cell"},{"key":"59563_CR14","doi-asserted-by":"publisher","first-page":"112603","DOI":"10.1016\/j.mce.2025.112603","volume":"607","author":"B Olajossy","year":"2025","unstructured":"Olajossy, B. & Slominski, A. T. Wolnicka\u2013Glubisz, A. Inhibition of the RIPK4 enhances suppression of human melanoma growth through vitamin D signaling. Mol. Cell. Endocrinol. 607, 112603 (2025).","journal-title":"Mol. Cell. Endocrinol."},{"key":"59563_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1083\/jcb.17.1.208","volume":"17","author":"ES Reynolds","year":"1963","unstructured":"Reynolds, E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell. Biol. 17, 208\u2013212 (1963).","journal-title":"J. Cell. Biol."},{"key":"59563_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2013\u2206\u2206CT Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"59563_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/biom14121573","volume":"14","author":"B Olajossy","year":"2024","unstructured":"Olajossy, B. et al. RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis. Biomolecules 14, 1573 (2024).","journal-title":"Biomolecules"},{"key":"59563_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2008.11.010","volume":"19","author":"RB Robey","year":"2009","unstructured":"Robey, R. B. & Hay, N. Is Akt the Warburg kinase?\u2014Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 19, 25\u201331 (2009).","journal-title":"Semin Cancer Biol."},{"key":"59563_CR19","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1091\/mbc.e06-07-0593","volume":"18","author":"HL Wieman","year":"2007","unstructured":"Wieman, H. L., Wofford, J. A. & Rathmell, J. C. Cytokine Stimulation Promotes Glucose Uptake via Phosphatidylinositol-3 Kinase\/Akt Regulation of Glut1 Activity and Trafficking. Mol. Biol. Cell. 18, 1437\u20131446 (2007).","journal-title":"Mol. Biol. Cell."},{"key":"59563_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.31083\/j.fbl2812368","volume":"28","author":"L Hua","year":"2023","unstructured":"Hua, L., Wu, J. H., Xu, J. Y., Wu, S. G. & Zhou, J. RIPK4 Promotes Cell Invasion and the Epithelial\u2013Mesenchymal Transition in Ovarian Cancer. Front. Biosci. 28, 368 (2023).","journal-title":"Front. Biosci."},{"key":"59563_CR21","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.1038\/srep11955","volume":"5","author":"DQ Liu","year":"2015","unstructured":"Liu, D. Q. et al. Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients. Sci. Rep. 5, 11955 (2015).","journal-title":"Sci. Rep."},{"key":"59563_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tcb.2018.11.006","volume":"29","author":"R Ferrari","year":"2019","unstructured":"Ferrari, R., Infante, E. & Chavrier, P. Nucleus\u2013Invadopodia Duo During Cancer Invasion. Trends Cell. Biol. 29, 93\u201396 (2019).","journal-title":"Trends Cell. Biol."},{"key":"59563_CR23","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.tcb.2022.07.002","volume":"32","author":"L Zhang","year":"2022","unstructured":"Zhang, L. & Wei, X. Orientational cell adhesions (OCAs) for tissue morphogenesis. Trends Cell. Biol. 32, 975\u2013978 (2022).","journal-title":"Trends Cell. Biol."},{"key":"59563_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tcb.2022.09.009","volume":"33","author":"M Parlani","year":"2023","unstructured":"Parlani, M., Jorgez, C. & Friedl, P. Plasticity of cancer invasion and energy metabolism. Trends Cell. Biol. 33, 388\u2013402 (2023).","journal-title":"Trends Cell. Biol."},{"key":"59563_CR25","doi-asserted-by":"publisher","first-page":"e70386","DOI":"10.1002\/cam4.70386","volume":"13","author":"IJ Tan","year":"2024","unstructured":"Tan, I. J., Parikh, A. K. & Cohen, B. A. Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology. Cancer Med. 13, e70386 (2024).","journal-title":"Cancer Med."},{"key":"59563_CR26","doi-asserted-by":"publisher","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"DA Scott","year":"2011","unstructured":"Scott, D. A. et al. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 286, 42626\u201342634 (2011).","journal-title":"J. Biol. Chem."},{"key":"59563_CR27","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1111\/jcmm.17844","volume":"27","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. SPI1 involvement in malignant melanoma pathogenesis by regulation of HK2 through the AKT1\/mTOR pathway. J. Cell. Mol. Med. 27, 2675\u20132683 (2023).","journal-title":"J. Cell. Mol. Med."},{"key":"59563_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12253-017-0363-7","volume":"25","author":"M D\u016fra","year":"2019","unstructured":"D\u016fra, M. et al. Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases. Pathol. Oncol. Res. 25, 361\u2013368 (2019).","journal-title":"Pathol. Oncol. Res."},{"key":"59563_CR29","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.21873\/anticanres.17199","volume":"44","author":"W Ma","year":"2024","unstructured":"Ma, W., Li, Z., Wen, J. & Yan, S. The Expression and Prognostic Value of Multiple Glucose Transporters in Cutaneous Melanoma. Anticancer Res. 44, 3747\u20133756 (2024).","journal-title":"Anticancer Res."},{"key":"59563_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1079\/BJN2002763","volume":"89","author":"IS Wood","year":"2003","unstructured":"Wood, I. S. & Trayhurn, P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. J. Nutr. 89, 3\u20139 (2003).","journal-title":"Br. J. Nutr."},{"key":"59563_CR31","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1158\/0008-5472.CAN-15-0491","volume":"75","author":"A Viale","year":"2015","unstructured":"Viale, A., Corti, D. & Draetta, G. F. Tumors and Mitochondrial Respiration: A Neglected Connection. Cancer Res. 75, 3687\u20133691 (2015).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59563-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59563-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59563-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:57Z","timestamp":1789560177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59563-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59563"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59563-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments from which the analyzed tissue samples originated were approved by the II Local Ethics Committee of the Institute of Pharmacology of the Polish Academy of Sciences (approval numbers: 82\/2023, 135\/2023, and 52\/2024).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28854"}}